New Delhi, March 21, 2026 – In a landmark achievement for medical research in India, scientists at the All India Institute of Medical Sciences (AIIMS) have announced a significant breakthrough in the treatment of acute myeloid leukaemia (AML), a type of cancer that affects the blood and bone marrow. The research, published this week in the prestigious journal The Lancet Oncology, details a novel therapeutic approach showing promising results in early-stage clinical trials.
The new treatment involves a combination of targeted drug therapy and immunotherapy, designed to specifically attack leukaemia cells while boosting the patient's own immune system to fight the disease. Current treatments for AML often involve aggressive chemotherapy and bone marrow transplants, which can have severe side effects. This new approach aims to reduce these side effects and improve long-term survival rates.
Targeted Therapy Shows Promise for Leukaemia Patients
The research team, led by Dr. Priya Sharma, Head of Haematology at AIIMS, has been working on this project for over five years. Dr. Sharma shared her excitement with News Reporter Live, saying, "We are incredibly encouraged by the results we have seen so far. The combination therapy has shown a significant reduction in leukaemia cells in the majority of patients, with manageable side effects. This offers a new ray of hope for those battling this aggressive disease."
The clinical trials involved 60 patients with newly diagnosed AML. The results indicated that patients receiving the combination therapy had a higher remission rate and longer overall survival compared to those receiving standard chemotherapy. While the findings are preliminary, doctors are optimistic about the potential of this new treatment approach.
Understanding Acute Myeloid Leukaemia (AML)
Acute myeloid leukaemia is a cancer that starts in the bone marrow, the soft inner part of bones where new blood cells are made. In AML, the bone marrow produces abnormal, immature white blood cells called myeloblasts. These cells crowd out healthy blood cells, leading to infections, anaemia, and bleeding. According to the Indian Council of Medical Research (ICMR), AML accounts for approximately 20% of all leukaemia cases in India, with an estimated 20,000 new cases diagnosed each year.
Speaking to News Reporter Live, Dr. Rajesh Kumar, a leading oncologist at Max Healthcare, Delhi, said, "This research from AIIMS is a significant step forward. AML is a challenging cancer to treat, and new therapies are desperately needed. The targeted approach offers the potential for more effective treatment with fewer side effects, but larger, multi-centre trials will be crucial to confirm these findings." Reportersays the research is a significant development for India.
Future Directions and Accessibility
The AIIMS team is now planning larger phase III clinical trials to further evaluate the efficacy and safety of the combination therapy. They are also working on making the treatment more accessible and affordable for patients across India. The government's Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (Health Insurance & Financial Aid) could play a vital role in ensuring that this innovative treatment reaches those who need it most.
Meanwhile, the WHO recommends early diagnosis and access to prompt treatment as key strategies for managing leukaemia. This breakthrough underscores the importance of investing in medical research and developing innovative therapies to combat life-threatening diseases.
Actionable Takeaways for the Public
- Early Detection: Be aware of the symptoms of leukaemia, such as unexplained fatigue, fever, frequent infections, and easy bleeding or bruising. Consult a doctor promptly if you experience any of these symptoms.
- Healthy Lifestyle: Maintain a healthy lifestyle with a balanced diet, regular exercise, and avoid smoking and excessive alcohol consumption. While these measures cannot prevent leukaemia, they can improve overall health and potentially reduce the risk of some cancers.
- Support Research: Support medical research initiatives and organisations working to find better treatments and cures for cancer.
Explore More on News Reporter Live
Frequently Asked Questions
What are the early symptoms of acute myeloid leukaemia (AML)?
Early symptoms of AML can include fatigue, fever, frequent infections, easy bleeding or bruising, bone pain, and swollen gums. It's important to consult a doctor if you experience these symptoms, especially if they are persistent.
What do doctors recommend for preventing leukaemia?
While there's no guaranteed way to prevent leukaemia, maintaining a healthy lifestyle with a balanced diet, regular exercise, and avoiding smoking and excessive alcohol can improve overall health. Also, avoid exposure to known carcinogens like benzene.
How could I get financial aid for cancer treatment in India?
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana is a government scheme that provides health insurance coverage for eligible families, which can help cover the costs of cancer treatment. There are also other NGO's and charitable trusts that provide financial help. Check our Health Insurance & Financial Aid section for more details.